The MP treatment plan was originally designed to treat an
inflammatory condition known as sarcoidosis. The treatment
consists of using the drug Benicar, combined with the avoidance
of all sources of vitamin D, and eventually adding various
antibiotics, especially minocycline. After being used by
sarcoidosis patients for some years, it was then theorized and
claimed that the treatment could treat other inflammatory
conditions. Eventually it was also claimed that it could treat
fibromyalgia and CFS, conditions which are not recognized by the
medical literature as being inflammatory in nature. Sarcoidosis
is an inflammatory disease, which is characterized by the
presence of granulomas. Granulomas often occur as an immune
response to certain types of infections and foreign bodies.
However, no specific cause for sarcoidosis has yet been found.
Many suspect an infectious cause, and studies are ongoing to
find the infection. Others believe that while an infection may
trigger the disease, that genetic and immune fact